These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22830343)

  • 1. Current trends in the chemotherapy of colorectal cancer.
    Berciano-Guerrero MA; Villa-Guzmán JC; Acosta-Guerrero R; Castañeda-Peñalvo G; Rodríguez-Flores J
    Curr Med Chem; 2012; 19(26):4414-30. PubMed ID: 22830343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive and prognostic factors in the complex treatment of patients with colorectal cancer.
    László L
    Magy Onkol; 2010 Dec; 54(4):383-94. PubMed ID: 21163770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current treatment strategies in elderly patients with metastatic colorectal cancer.
    Arkenau HT; Chua YJ; Cunningham D
    Clin Colorectal Cancer; 2007 May; 6(7):508-15. PubMed ID: 17553199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
    Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Fruth B; Meyerhardt JA; Schrag D; Greene C; O'Neil BH; Atkins JN; Berry S; Polite BN; O'Reilly EM; Goldberg RM; Hochster HS; Schilsky RL; Bertagnolli MM; El-Khoueiry AB; Watson P; Benson AB; Mulkerin DL; Mayer RJ; Blanke C
    JAMA; 2017 Jun; 317(23):2392-2401. PubMed ID: 28632865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment dilemmas of cetuximab combined with chemotherapy for metastatic colorectal cancer.
    Wen F; Li Q
    World J Gastroenterol; 2016 Jun; 22(23):5332-41. PubMed ID: 27340349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The chemotherapy of advanced colorectal carcinoma in the elderly patient. The new oral fluoropyrimidines].
    Di Costanzo F; Sdrobolini A; Gasperoni S; Basirat F
    Minerva Med; 1999; 90(7-8):234-41. PubMed ID: 10719427
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy for colorectal cancers].
    Lièvre A; Mitry E
    J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 10. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interpretation of the updates of NCCN 2017 version 1.0 guideline for colorectal cancer].
    Chen G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):28-33. PubMed ID: 28105616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemotherapy in colorectal carcinoma.
    Levitan N
    Surg Clin North Am; 1993 Feb; 73(1):183-98. PubMed ID: 7678944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
    [No Abstract]   [Full Text] [Related]  

  • 15. New possibilities in chemotherapy for colorectal cancer.
    Bekradda M; Cvitkovic E
    Ann Oncol; 1999; 10 Suppl 6():105-11. PubMed ID: 10676561
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oxaliplatinum in combination with 5-FU/FA in first-line chemotherapy of metastatic colorectal cancer: a new era in therapeutic strategy].
    Tumori; 2000; 86(2):A1-4. PubMed ID: 10855861
    [No Abstract]   [Full Text] [Related]  

  • 17. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
    Lee YC; Su CY; Lin YF; Lin CM; Fang CY; Lin YK; Hsiao M; Chen CL
    Oncotarget; 2017 Feb; 8(7):12120-12132. PubMed ID: 28076332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant cytotoxic chemotherapy for colorectal cancer: the present position.
    Taylor I
    Aust N Z J Surg; 1988 Sep; 58(9):687-91. PubMed ID: 2977942
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging drugs in refractory colorectal cancer.
    Nobili S; Galletta A; Brugia M; Tassi R; Petreni P; Landini I; Mini E
    Future Med Chem; 2015 Aug; 7(12):1491-501. PubMed ID: 26293581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
    Jain VK; Hawkes EA; Cunningham D
    Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.